72 Chapter 3 Table 4. Continued Reporting elements Agreement (%) Background Reporting elements before discharge (index admission) 20. Mortality 100 Evidence based 21. Re-interventions until discharge 100 Evidence based 22. Stoma creation 100 Evidence based 23. Diagnostic modality for AL 96.15 Evidence based 24. Length of hospital stay 92.31 Evidence based 25. Length of stay in the ICU 84.62 Evidence based 26. Serial CRP measurement 84.62 Evidence based Reporting elements after discharge – 30 days AND up to 90 days 27. Mortality 100 Evidence based 28. Readmission 100 Evidence based 29. Re-interventions after initial discharge 100 Evidence based 30. Stoma creation and closure 100 Evidence based 31. Diagnostic modality for AL 96.15 Evidence based 32. Anastomotic complication 96.15 Patient centered 33. Length of hospital stay 88.46 Evidence based 34. Length of stay in the ICU 84.61 Evidence based Reporting elements after 90 days (long term) 35. Re-interventions after 90 days * 100 Evidence based 36. Stoma information * 96.15 Evidence based 37. Anastomotic complications * 96.15 Patient centered 38. Oncological outcomes ** 96.15 Evidence based 39. Mortality ** 96.15 Evidence based 40. Anastomotic status * 92.31 Expert opinion 41. Functional outcomes: LARS (LARS score) ** 88.46 Patient centered 42. Quality of life assessment (EQ-5D score) ** 84.62 Patient centered 43. Functional outcomes: Incontinence (Wexner FI score) ** 80.76 Patient centered AV, anal verge; FI, fecal incontinence; ICU, intensive care unit; LARS, low anterior resection syndrome. * Up to 1 year; ** At 1, 2 (when possible) and 5 years (when possible). DISCUSSION Prior attempts to achieve consensus on definitions of colorectal AL have had limited success. As demonstrated in a recent systematic review of the quality of reporting of AL across CRC trials, substantial variability in the reporting of contributing factors, diagnostic modalities, interventions and impact of colorectal AL on functional and oncologic outcomes persists. These variables are of important value not only to patients, but also administrators, quality officers, payers, and industry 13,23-28.
RkJQdWJsaXNoZXIy MTk4NDMw